B. Rossin, A. Amar-hoffet, C. Melone, and N. Berdah, Epidémiologie de la fertilité, Journal Gynécologie & Obstétrique Pratique, pp.25-2017

, Site fiv.fr, rubriques la Fiv et déroulement d'une FIV

P. Clément, Consequences of stimulation on oocyte quality, Gynécologie Obstétrique Fertil, vol.35, issue.9, pp.890-897, 2007.

R. Kwang-yul-cha and . Chian, Maturation in vitro of immature human oocytes for clinical use, Human Reproduction Update, vol.4, issue.2, pp.103-120, 1998.

, Site fivfrance.com, rubrique traitements et protocoles, principaux protocoles en AMP

P. Feuerstein, V. Cadoret, R. Dalbies-tran, F. Guérif, and D. Royère, Le dialogue ovocytecumulus. Gynécologie Obstétrique Fertil, vol.34, pp.793-800, 2006.

, Site ebiologie.fr, rubriques la reproduction sexuée : ovogenèse et folliculogenèse

A. Hazout, Développement folliculaire ovarien induit : bases théoriques et applications thérapeutiques, Contracept. Fertil, vol.27, issue.3, pp.203-209, 1999.

Y. Lin, Y. Puyu, C. Yanrong, Z. Jinliang, Z. Xinyu et al., Factors inducing decreased oocyte maturation rate: a retrospective analysis of 20,939 ICSI cycles, Archives of Gynecology and Obstetrics, vol.4, 2018.

D. Royère, Maturation ovocytaire : peut-on définir la compétence d'un ovocyte, Journal Gynecol Obstet Biol Reprod, vol.35, issue.2, pp.2-8, 2006.

R. T. Scott, G. E. Hofmann, S. J. Muasher, A. A. Acosta, D. K. Kreiner et al., Correlation of follicular diameter with oocyte recovery and maturity at the time of transvaginal follicular aspiration, J in vitro Fert Embryo Transf, vol.6, pp.73-78, 1989.

D. S. Ko, S. Lee, D. Park, K. M. Yang, and C. K. Lim, Pregnancy and fertilization potential of immature oocytes retrieved in intracytoplasmic sperm injection cycles, Clin Exp Reprod Med, vol.42, issue.3, pp.118-143, 2015.

S. B. Shin, J. W. Cho, S. Lee, K. M. Yang, C. K. Lim et al., Fertilization and pregnancy potential of immature oocytes from stimulated intracytoplasmic sperm injection cycles, Clin Exp Reprod Med, vol.40, issue.1, pp.7-11, 2013.

J. D'après-la-communication-de, O. Fiori, and J. Mandelbaum, Peut-on prévoir la qualité ovocytaire par la qualité de la réponse, J Gynecol Obstet Biol Reprod, vol.35, issue.cahier2, pp.2-47, 2006.

L. U. Yuechao, Patients with a high proportion of immature and meiotically resistant oocytes experience defective nuclear oocyte maturation patterns and impaired pregnancy outcomes. Reproductive BioMedicine Online, pp.30037-30040, 2017.

S. U. Chen, H. N. Ho, H. F. Chen, S. C. Huang, T. Y. Lee et al., Intracytoplasmic sperm injection (ICSI) for severe semen abnormalities: dissecting the tail of spermatozoa at the tip, Hum Reprod, vol.11, pp.2640-2644, 1996.

D. Vos, A. Van-de-velde, H. Joris, and H. , Van Steirteghem A. In-vitro matured metaphase-I oocytes have a lower fertilization rate but similar embryo quality as mature metaphase-II oocytes after in-tracytoplasmic sperm injection, Hum Reprod, vol.14, pp.1859-63, 1999.

A. M. Junca, J. Mandelbaum, J. Belaisch-allart, J. Salat-baroux, M. Plachot et al., Oocyte maturity and quality: value of intra-cytoplasmic sperm injection. Fertility of microinjected oocytes after in vitro maturation, Contracept Fertil Sex, vol.23, pp.463-468, 1995.

B. Mcavey, A. Zapantis, S. K. Jindal, H. J. Lieman, and A. J. Polotsky, How many eggs are needed to produce an assisted reproductive technology baby: is more always better?, Fertil Steril, vol.96, issue.2, pp.332-335, 2011.

, World Health Organization. WHO Laboratory Manual for the Examination and Processing of Human Semen, 2010.

, consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome, Fertil Steril, vol.81, issue.1, pp.19-25, 2003.

T. Fréour and P. Barrière, Place actuelle de la réserve ovarienne dans le bilan et la prise en charge d'une infertilité. 35 ème journée nationale CNGOF, pp.19-37, 2011.

J. A. Rock, Zoladex Endometriosis Study Group. The revised American Fertility Society classification of endometriosis: reproducibility of scoring, Fertile Steril, vol.63, issue.5, 1995.

, Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology. The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting, Human Reproduction, issue.6, pp.1270-1283, 2011.

H. N. Ciray, A. Campbell, I. E. Agerholm, J. Aguilar, S. Chamayou et al., Proposed guidelines on the nomenclature and annotation of dynamic human embryo monitoring by a time-lapse user group, Hum Reprod, vol.29, issue.12, pp.2650-60, 2014.

E. Van-royen, K. Mangelschots, D. Neubourg, D. Valkenburg, M. Van-de-meerssche et al., Characterization of a top quality embryo, a step towards single-embryo transfer, Hum Reprod Oxf Engl, vol.14, issue.9, pp.2345-2354, 1999.

S. Bar-ami, E. Zlotkin, J. M. Brandes, and J. Itskovitz-eldor, Failure of meiotic competence in human oocytes, Biol Reprod, vol.50, issue.5, pp.1100-1107, 1994.

I. Halvaei, A. Khalili, M. Razi, M. H. Nottola, and S. A. , The effect of immature oocytes quantity on the rates of oocytes maturity and morphology, fertilization, and embryo development in ICSI cycles, J Assist Reprod Genet, vol.29, issue.8, pp.803-813, 2012.

G. A. Hill, M. Freeman, M. C. Bastias, B. J. Rogers, . Herbert et al., The influence of oocyte maturity and embryo quality on pregnancy rate in a program for in vitro fertilization-embryo transfer, Fertil Steril, vol.52, issue.5, pp.801-807, 1989.

L. Bardiaux, Immaturité ovocytaire : analyse de 1017 tentatives de FIV-ICSI au Centre Hospitalier Régional et Universitaire de Lille, vol.2016, pp.1-26

J. D. Kok, C. Looman, S. M. Weima, and E. R. Velde, A high number of oocytes obtained after ovarian hyperstimulation for in vitro fertilization or intracytoplasmic sperm injection is not associated with decreased pregnancy outcome, Fertil Steril, vol.85, issue.4, pp.918-924, 2006.

C. Wittemer, J. Ohl, K. Bettahar-lebugle, S. Viville, and I. Nisand, A quantitative and morphological analysis of oocytes collected during 438 IVF cycles, J Assist Reprod Genet, vol.17, issue.1, pp.44-50, 2000.

N. P. Polyzos, P. Drakopoulos, J. Parra, A. Pellicer, S. Santos-ribeiro et al., Cumulative live birth rates according to the number of oocytes retrieved after the first ovarian stimulation for in vitro fertilization/intracytoplasmic sperm injection: a multicenter multinational analysis including 15,000 women, Fertil Steril, vol.110, issue.4, 2018.

J. Zhou, B. Wang, Y. Hu, and H. Sun, Association between the number of oocytes retrieved and cumulative live birth rate in women aged 35-40 years undergoing long GnRH agonist IVF/ ICSI cycles. Gynecologic endocrinology and reproductive medicine, pp.4503-4512, 2017.

K. Y. Cha, In vitro fertilization using immature follicular oocytes harvested from ovarian tissue, Progress in Infertility, vol.7, pp.99-112, 1992.

. Moore, Oocyte maturation arrest more common in younger patients undergoing IVF/ ICSI. Fertil Steril, 2007.

H. J. Lee, B. C. Jee, C. S. Suh, S. H. Kim, and S. Y. Moon, Oocyte maturity in relation to woman's age in in vitro fertilization cycles stimulated by single regimen, Yonsei Med J, vol.53, issue.1, pp.181-185, 2012.

C. Lenoble, J. Guibert, G. Lefebvre, and M. Dommergues, Influence du poids sur les taux de succès en fécondation in vitro. Gynécologie Obstétrique Fertil, vol.36, pp.940-944, 2008.

N. Chaouache, M. Ajina, M. Gaddas, A. Miled, Z. Tabka et al., Effets de l'hyperlipidémie sur la qualité embryonnaire et les résultats de la fécondation in vitro chez des femmes tunisiennes infertiles, Nutr Clin Métabolisme, vol.29, issue.3, pp.140-146, 2015.

. Mendes-pereira, Outcome of ICSI cycles in patients with polycystic ovary syndrom and in normo-ovulatory women, Fertil Steril, p.459, 2006.

J. Sigala, C. Sifer, D. Dewailly, G. Robin, A. Bruyneel et al., Is polycystic ovarian morphology related to a poor oocyte quality after controlled ovarian hyperstimulation for intracytoplasmic sperm injection? Results from a prospective, comparative study, Fertil Steril, vol.103, issue.1, pp.112-120, 2015.

L. Boucret, J. M. Chao-de-la-barca, C. Morinière, V. Desquiret, -. Ferré et al., Relationship between diminished ovarian reserve and mitochondrial biogenesis in cumulus cells, Hum Reprod Oxf Engl, vol.30, issue.7, pp.1653-64, 2015.
URL : https://hal.archives-ouvertes.fr/hal-02056608

T. J. Child, C. Sylvestre, I. Pirwany, and S. L. Tan, Basal serum levels of FSH and estradiol in ovulatory and anovulatory women undergoing treatment by in-vitro maturation of immature oocytes, Hum Reprod, vol.17, issue.8, pp.1997-2002, 2002.

A. L. Mikkelsen, A. M. Andersson, N. E. Skakkebaek, and S. Lindenberg, Basal concentrations of oestradiol may predict the outcome of in-vitro maturation in regularly menstruating women, Hum Reprod, vol.16, pp.862-867, 2001.

F. Guerif, M. Lemseffer, M. Couet, O. Gervereau, V. Ract et al., Serum antimüllerian hormone is not predictive of oocyte quality in vitro fertilization, Ann Endocrinol, 2009.

, Site guide-de-l-infertilite.fr, rubriques infertilité et stérilité, la femme et l'infertilité, l'insuffisance ovarienne, vol.70, pp.230-234

B. C. Jee, S. Y. Ku, C. S. Suh, K. C. Kim, W. D. Lee et al., Serum anti-Müllerian hormone and inhibin B levels at ovulation triggering day can predict the number of immature oocytes retrieved in in vitro fertilization cycles, J Korean Med Sci, vol.23, issue.4, pp.657-661, 2008.

D. Dewailly, Le dosage d'AMH peut-il prédire la réponse ovarienne et la qualité ovocytaire? Gynécologie Obstétrique Fertil, vol.36, pp.4-5, 2008.

J. Smeenk, F. Sweep, G. A. Zielhuis, J. Kremer, C. Thomas et al.,

, Antimüllerian hormone predicts ovarian responsiveness, but not embryo quality or pregnancy, after in vitro fertilization or intracyoplasmic sperm injection, Fertil Steril, 2007.

D. M. Wunder, J. Guibourdenche, M. H. Birkhäuser, and N. A. Bersinger, Anti-Müllerian hormone and inhibin B as predictors of pregnancy after treatment by in vitro fertilization/ intracytoplasmic sperm injection, Fertil Steril, vol.90, issue.6, pp.2203-2213, 2008.

T. Ebner, M. Sommergruber, M. Moser, O. Shebl, E. Schreier-lechner et al., Basal level of anti-Müllerian hormone is associated with oocyte quality in stimulated cycles, Hum Reprod Oxf Engl, vol.21, issue.8, pp.2022-2028, 2006.

C. Takahashi, A. Fujito, M. Kazuka, R. Sugiyama, H. Ito et al., Anti-Müllerian hormone substance from follicular fluid is positively associated with success in oocyte fertilization during in vitro fertilization, Fertil Steril, vol.89, issue.3, pp.586-91, 2008.

S. L. Broer, B. Mol, D. Hendriks, and F. Broekmans, The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count, Fertil Steril, vol.91, issue.3, pp.705-719, 2009.

S. Salama, A. Torre, B. Paillusson, A. Thomin, B. Brahim et al., Ovarian stimulation monitoring: past, present and perspective. Gynécologie Obstétrique & amp, Fertilité, vol.39, issue.4, pp.245-254, 2001.

T. J. Child, B. Gulekli, and S. L. Tan, Success during in-vitro maturation (IVM) of oocyte treatment is dependent on the numbers of oocytes retrieved which are predicted by early follicular phase transvaginal ultrasound measurement of the antral follicle count and peak ovarian stromal blood flow velocity, Hum. Reprod, vol.16, p.41, 2001.

K. Jayaprakasan, S. Deb, M. Batcha, J. Hopkisson, I. Johnson et al., The cohort of antral follicles measuring 2-6 mm reflects the quantitative status of ovarian reserve as assessed by serum levels of anti-Müllerian hormone and response to controlled ovarian stimulation, Fertil Steril, vol.94, issue.5, pp.1775-1781, 2010.

Y. Hsieh, Antral follicle counting in predicting the retrieved oocyte number after ovarian hyperstimulation, J Assist Reprod Genet, vol.18, issue.6, pp.320-324, 2001.

R. Webb, P. C. Garnsworthy, B. K. Campbell, and M. G. Hunter, Intra-ovarian regulation of follicular development and oocyte competence in farm animals, Theriogenology, vol.68, pp.22-29, 2007.

E. Bosch, E. Labarta, E. Kolibianakis, M. Rosen, and D. Meldrum, Regimen of ovarian stimulation affects oocyte and therefore embryo quality, Fertil Steril, vol.105, issue.3, pp.560-70, 2016.

V. L. Baker, M. B. Brown, B. Luke, G. W. Smith, and J. J. Ireland, Gonadotropin dose is negatively correlated with live birth rate: analysis of more than 650,000 assisted reproductive technology cycles, Fertil Steril, vol.104, issue.5, pp.1145-52, 2015.

T. Shavit, E. Shalom-paz, N. Samara, N. Aslih, M. Michaeli et al., Comparison between stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF with GnRH antagonist protocol, Gynecol Endocrinol Off J Int Soc Gynecol Endocrinol

L. Rombauts, Is there a recommended maximum starting dose of FSH in IVF?, J Assist Report Genet, vol.24, issue.8, pp.343-352, 2007.

F. Coelho, L. F. Aguiar, G. Cunha, N. Cardinot, and E. Lucena, Comparison of results of cycles treated with modified mild protocol and short protocol for ovarian stimulation, Int J Reprod Med, vol.2014, p.367474, 2014.

P. Qu-;-merviel, E. Lourdel, R. Cabry, V. Boulard, F. Scheffler et al., est-ce que la mild stimulation ?What is mild stimulation?, Gynécologie Obstétrique & Fertilité, vol.40, issue.9, pp.467-471, 2012.

J. R. Martin, N. G. Mahutte, A. Arici, and D. Sakkas, Impact of duration and dose of gonadotrophins on IVF outcomes, Reprod Biomed Online, vol.13, issue.5, pp.645-50, 2006.

B. Wirleitner, J. Okhowat, L. Vi?tejnova, M. Králí?kova, M. Karlíkova et al., Relationship between follicular volume and oocyte competence, blastocyst development and live-birth rate: optimal follicle size for oocyte retrieval, 2018.

L. Clark, J. Stanger, and M. Brinsmead, Prolonged follicle stimulation decreases pregnancy rates after in vitro fertilization, Fertil Steril, vol.55, pp.1192-1194, 1991.

N. Laufer, A. H. Decherney, B. C. Tarlatzis, A. L. Zuckerman, M. L. Polan et al., Delaying human chorionic gonadotropin administration in human menopausal gonadotropin-induced cycles decreases successful in vitro fertilization of human oocytes, Fertil Steril, vol.42, pp.198-203, 1984.

H. G. Al-inany, M. A. Youssef, M. Aboulghar, F. Broekmans, M. Sterrenburg et al., Gonadotrophin-releasing hormone antagonists for assisted reproductive technology

, Cochrane Database Syst Rev, p.1750, 2011.

E. Baart, E. Martini, M. Eijkemans, D. Van-opstal, N. Beckers et al., Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial, Hum Reprod, vol.22, pp.980-988, 2007.

D. Nogueira, S. Friedler, M. Schachter, A. Raziel, R. Ron-el et al., Oocyte maturity and preimplantation development in relation to follicle diameter in gonadotropin-releasing hormone agonist or antagonist treatments, Fertil Steril, vol.85, issue.3, pp.578-83, 2006.

E. Loumaye, P. Engrand, C. Howles, and O. , Assessment of the role of serum luteinizing hormone and estradiol response to follicle-stimulating treatment outcome. fertility and sterility, vol.67, pp.889-899, 1997.

G. Levy, M. Hill, S. Beall, J. D. Pilgrim, M. Payson et al., Falling estradiol levels on day after human chorionic gonadotropin administration in assisted reproductive technology cycles are not predictive of decreasing oocyte maturity or pregnancy rates, J Reprod Med, vol.59, issue.5-6, pp.255-264, 2014.

A. Weiss, R. Neril, J. Geslevich, M. Lavee, R. Beck-fruchter et al., Lag time from ovulation trigger to oocyte aspiration and oocyte maturity in assisted reproductive technology cycles: a retrospective study, Fertil Steril, vol.102, issue.2, pp.419-442, 2014.

W. Wang, X. H. Zhang, and W. H. Wang, The time interval between hCG priming and oocyte retrieval in ART program: a meta-analysis, J Assist Report Genet, vol.28, issue.10, pp.901-911, 2011.

A. Delvigne, Comment améliorer les résultats d'une tentative de fécondation in vitro en changeant la stimulation ovarienne?, Gynecol Obstet, vol.17, issue.1, pp.79-86, 2016.

D. Griffin, R. Feinn, L. Engmann, J. Nulsen, T. Budinetz et al., Dual trigger with gonadotropin-releasing hormone agonist and standard dose human chorionic gonadotropin to improve oocyte maturity rates, Fertile Steril, vol.102, issue.2, pp.405-414, 2014.

E. Zilberberg, J. Haas, S. Dar, A. Kedem, R. Machtinger et al., Co-administration of GnRH-agonist and hCG, for final oocyte maturation (double trigger), in patients with low proportion of mature oocytes, Gynecol Endocrinol Off J Int Soc Gynecol Endocrinol, 2015.

M. Youssef, H. I. Abdelmoty, M. Ahmed, and M. Elmohamady, GnRH agonist for final oocyte maturation in GnRH antagonist co-treated IVF/ICSI treatment cycles: Systematic review and meta-analysis, J Adv Res, vol.6, issue.3, pp.341-350, 2015.

S. Beall, C. Brenner, and J. Segars, Oocyte maturation failure: a syndrome of bad eggs, Fertil Steril, vol.94, issue.7, pp.2507-2513, 2010.

D. Levran, J. Farhi, H. Nahum, M. Glezerman, and W. , Maturation arrest of human oocytes as a cause of infertility: case report, Hum Reprod, vol.17, issue.6, pp.1604-1609, 2002.

A. Hourvitz, E. Maman, M. Brengauz, R. Machtinger, and J. Dor, In vitro maturation for patients with repeated in vitro fertilization failure due to "oocyte maturation abnormalities, Fertil Steril, vol.94, issue.2, pp.496-501, 2010.

B. Gulekli, S. Olgan, and F. Aydiner, In vitro oocyte maturation from unstimulated cycles: does it offer a realistic chance to overcome the problem of repeated oocyte maturation arrest in IVF?, Arch Gynecol Obstet, vol.283, issue.1, pp.133-134, 2011.

L. Théron-gérard, M. Pasquier, C. Czernichow, I. Cédrin-durnerin, and H. J. , Polymorphisme du gène du récepteur de la FSH et fonction ovarienne, Gynécologie Obstétrique & fertilité, vol.35, issue.2, pp.135-141, 2007.

T. Forges and P. Monnier-barbarino, La maturation ovocytaire in vitro : intérêts, indications, résultats. CNGOF, vol.29, pp.225-253, 2005.

Y. Shu, J. Gebhardt, J. Watt, J. Lyon, D. Dasig et al., Fertilization, embryo development, and clinical outcome of immature oo-cytes from stimulated intracytoplasmic sperm injection cycles, Fertil Steril, vol.87, pp.1022-1029, 2007.

C. Alvarez, C. Garcia-garrido, R. Taronger, G. De-merlo, and G. , In vitro maturation, fertilization, embryo development & clinical outcome of human metaphase-I oocytes retrieved from stimu-lated intracytoplasmic sperm injection cycles, Indian J Med Res, vol.137, pp.331-339, 2013.

S. E. Lanzendorf, M. B. Zelinski-wooten, R. L. Stouffer, and D. P. Wolf, Matu-rity at collection and the developmental potential of rhesus monkey oocytes, Biol Reprod, vol.42, pp.703-714, 1990.

L. Vanhoutte, D. Sutter, P. Van-der-elst, J. Dhont, and M. , Clinical benefit of metaphase I oocytes, Reprod Biol Endocrinol, vol.3, pp.71-65, 2005.